Hypertension is the leading risk factor for cardiovascular death worldwide, yet current diagnostic methods often fail to provide an accurate blood pressure profile, leading to gaps in care.
Sonion Health was founded to transform hypertension management using patented advanced technology, developed with AI and machine learning algorithms. Our unique platform provides accurate data and actionable insights, enabling clinicians to make more informed decisions and improve patient outcomes at any time, from anywhere.
Hypertension is often called the “silent killer” because it typically presents with no obvious symptoms. Many individuals are reactive rather than proactive in managing their condition, and both healthcare providers and patients may lack the necessary information for effective medication management. As a result, hypertension is the leading risk factor for cardiovascular death worldwide. It affects all demographic groups, with approximately 120 million adults in the United States and 1.3 billion hypertensive adults globally.
Unlike other vital signs, such as pulse oximetry, ECG, temperature, and respiration, blood pressure measurement remains underdeveloped and lacks continuous access. There is also White Coat Hypertension, where 10% to 30% of adults exhibit elevated blood pressure in healthcare settings. And Masked Hypertension, where up to 30% of adults with normal BP at the doctor’s office may have elevated readings at home or BP rises during sleep, called Nocturnal Hypertension. Some patients who have high blood pressure do not respond well to aggressive medical treatment, and about 20% of patients with Resistant hypertension.
120 million
adults in the US and 1.3 billion adults worldwide
60 Million
Half of those affected are undiagnosed (60 million in us)
90 million
3 in 4 have uncontrolled hypertension (90 million in US)
130 billion
anually spent, 700k mortality in the US
The Innovative “Sonion Health Band” and machine learning algorithm “Health-AI“.
The Sonion Health Band and Health-AI is wearable device that offers continuous access to clinically accurate blood pressure monitoring throughout daily activities, including during sleep. Designed specifically for patients and thoroughly tested, it enables precise diagnosis and real-time management of hypertension.
* (This footnote will refer to the disclaimer at the bottom of the page)
By seamlessly integrating into existing clinical workflows, this device provides healthcare providers with remote, data-driven insights that enhance treatment decisions, reduce preventable cardiovascular events, and lower healthcare costs. By decreasing the need for in-person visits, it improves patient adherence to care and optimizes clinical resources, making proactive hypertension management both scalable and efficient.
Our innovative Laser Doppler Flowmetry (LDF) bio-signal technology provides an advanced optical measurement of arterial flow velocity. Developed with AI and a machine learning algorithm (Health-AI) that interprets the signal for accurate measurements. Distinguishing itself from existing methods such as photoplethysmography (PPG), which often struggle with accuracy due to artery wall stiffness and body motion artifacts.
Through our innovative technology and machine learning algorithm, our solution provides a comprehensive patient blood pressure profile, enabling accurate hypertension diagnosis and effective medical management. This helps keep hypertension under control and facilitates better quality measurements.
Why this matters:
Age-agnostic Accuracy: Our flow waveform method overcomes PPG limitations in elderly populations by maintaining high signal fidelity despite arterial stiffness.
Physiological Precision: Extracts BP-critical features like pulse pressure, systolic/diastolic points, and reflection timing.
Real-World Robustness: Accounts for physiological changes during activity, ensuring reliable blood pressure (BP) estimates across various conditions.
Our innovative approach is supported by a robust intellectual property portfolio, featuring seven filed U.S. patents. We are actively expanding our IP portfolio on a weekly basis.
LDF RAW DATA
SIGNAL PROCESSING
Machine learning algorithms (health-ai)
accurate blood pressure diagnosis & management
Core Team
Jim Fidacaro
EVP, Sonion
25+ yrs MedTech, Digital Health, B2B2C and patient monitoring
Yan Apelfeld
Head of Research & Technology
25+ yrs in HW, SW, AI & ML development
Advisors
Marlou Janssen-Counotte
Board Member
25+ years senior executive MedTech
Christy Foreman
Board Advisor – Regulatory
Former Director of the Office of Device
Evaluation at FDA
Prof. george stergiou
Board Advisor – Clinical
President International Society of Hypertension
Investigational device. Limited by Federal law to investigational use. Not available for sale or commercial use.